Salient Surgical Technologies is a private company that develops and markets innovative surgical devices based on the company’s proprietary Transcollation™ technology. Transcollation technology simultaneously integrates saline and radiofrequency energy allowing thermal energy to gently reach targeted tissues via saline-induced liquid electrodes. The company’s Aquamantys System utilizes Transcollation technology to allow surgeons to control bleeding during solid organ resection, orthopedic reconstructive and spine surgery. Over 150,000 patients worldwide have been treated with the company’s products to date.

Salient Surgical was acquired by Medtronic in 2009 for approximately $550 million.